Akums Drugs And Pharmaceuticals Limited IPO

Akums Drugs and Pharmaceuticals IPO

[{"selector":"#anim-3fe1289b-1d30-42ef-8acb-a4e8e1198033 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-29.918749878147754%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-b508d86d-b19f-46c7-a85a-24e0eb0a966c","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b6312e94-1509-4d9d-bdb7-c96950fcc8cf","keyframes":{"transform":["translate3d(-115.53399%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8370ea39-2a3e-4035-99cb-152c57f921e2","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-2e21a60b-6e23-4f8d-9281-653b534e0568","keyframes":{"transform":["translate3d(115.33547%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Akums Drugs IPO worth INR 1,856.74cr includes a fresh issue of INR 680 cr and an offer to sell INR 1,176.74cr, aimed at reducing debt, funding working capital, acquisitions, and corporate purposes. Read more

Important Details

[{"selector":"#anim-074d49a2-9355-43df-af8f-a7190ac5ed68 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-34.16562490391763%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-d5175864-6ec9-45d3-8be7-426c20397445","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-3bf15edb-6cad-4d58-b8c7-724dd9add2b7","keyframes":{"transform":["translate3d(-115.53399%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-828c810c-7cbf-400e-9e7e-1293800d66f3","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-1ddc7560-67ab-43d6-beef-7a664e459ea7","keyframes":{"transform":["translate3d(115.97445%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Open Date : July 30, 2024 Close Date : August 1, 2024 Allotment Date: August 2, 2024 Listing Date: August 6, 2024 Important Details

Important Details

[{"selector":"#anim-bbfaeeb2-2c90-48fe-8bfd-166268c8f908 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-31.24062488616884%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-4bf8339d-6ba0-4e8d-a274-d4c92751b2b6","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-04213bde-a9ed-466c-8543-8e978b9d6993","keyframes":{"transform":["translate3d(-115.53399%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-57401850-7249-4bb0-baed-ba1d9cdb1116","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ad7d2c90-1335-4613-b22a-711c43f0fa4b","keyframes":{"transform":["translate3d(115.97445%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] IPO Price: INR 646-679 per share Lot Size: 22 Shares Total Issue Size: INR 1,865.74 crores Important Details

Fundamental Analysis

[{"selector":"#anim-f4fb1df6-a418-4249-967b-60fe3e71e0b0 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-31.21249988599818%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-a93cf19f-cec0-4699-b4ac-7dac8b6d4a34","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f0c5a551-4fdc-4cbf-aee1-68cbc5cd25fc","keyframes":{"transform":["translate3d(-115.53399%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8243f419-f816-4768-a4f6-fd62a6efab6e","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-55799445-8a3b-494a-98b4-154f277f1887","keyframes":{"transform":["translate3d(115.97445%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Akums Drugs & Pharmaceuticals IPO analysis shows mixed performance: 1. Revenue decreased. 2. Increased equity & liabilities. 3. Improved profitability with higher PAT & RoNW. 4. Declined EPS, Growing total assets, indicating expansion. Fundamental Analysis

Peer Comparison

[{"selector":"#anim-fb367223-9259-446c-8601-4381e26dd3bc [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-31.24062488616884%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-8e6c9ab6-8bd1-4227-9733-6ceb51868b00","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-2554db47-22c9-4432-95b8-362f15254100","keyframes":{"transform":["translate3d(-115.53399%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-3c8a1522-06f7-4018-8bd6-51d419f040ff","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-186fb411-2398-490e-be55-dda5fae079b9","keyframes":{"transform":["translate3d(117.85715%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Akums Drugs, Divi’s Labs, Suven Pharma, Gland Pharma, Torrent Pharma, Alkem Labs, Eris Lifesciences, JB Chemicals, Mankind Pharma, and Innova Captab show varied financial metrics in profitability, EPS, RoNW, and assets. Peer Comparison

Objective

[{"selector":"#anim-c659f3b3-0955-4e22-9f42-2b70fa30a66c [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-31.24062488616884%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-bd573add-a8a2-4ec4-90ae-25d0d8bb6534","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b28dd659-52bc-4d69-9d93-72d1d9c8cfec","keyframes":{"transform":["translate3d(-115.53399%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-386d3a0e-04e1-4c95-b73a-6fcb52435579","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-057cc1cd-42cf-4d67-83c3-5b16db535201","keyframes":{"transform":["translate3d(117.85715%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Akums Drugs And Pharmaceuticals Ltd IPO Objective 1. Repay/prepay company & subsidiary debts. 2. Fund incremental working capital needs. 3. Pursue inorganic growth through acquisitions. Objective

Risks And Challenges

[{"selector":"#anim-16aaebda-18d0-45f0-acf9-947b9abd582a [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-10.170312529309548%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-44743fc1-f0ea-45de-b692-61d1893f48f2","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d9aef455-b9cd-4ab6-a526-ef05379c960f","keyframes":{"transform":["translate3d(-115.53399%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-1ca2acb5-dd1a-4e96-ba62-44d4351eb668","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8d8c4e1a-04c6-48af-b821-5e81e2d080b7","keyframes":{"transform":["translate3d(118.18181%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Akums Drugs And Pharmaceuticals Ltd IPO risks : 1. Economic, regulatory, and disaster impacts. 2. Power outages or machinery breakdowns. 3. Order cancellations or quality issues. Risks And Challenges

Check Out More IPO Review Articles

[{"selector":"#anim-aa8a41c0-dda7-42f3-822a-d2f9b5f90ecc [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-29.918749878147754%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-ea2ad9fb-35d2-466c-91d9-dedf49ddc480","keyframes":{"opacity":[0,1]},"delay":300,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c46fe763-8119-42d1-80a5-09bddf8fe5c5","keyframes":{"transform":["translate3d(84.21055%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":300,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-641240aa-782e-4697-9a46-5e9f8e7e610b","keyframes":{"opacity":[0,1]},"delay":300,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8ca4bd19-1191-477e-aaf7-3d94c603e53a","keyframes":{"transform":["translate3d(56.00001%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":300,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-27bcc040-46f1-4481-8279-39ebc39ef54c","keyframes":{"transform":["translate3d(-135.29412%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(.2, 0, .8, 1)","fill":"both"}] [{"selector":"#anim-89c65841-2820-4b40-9169-f7c22cc01b84","keyframes":{"transform":["rotateZ(-180deg)","rotateZ(0deg)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(.2, 0, .5, 1)","fill":"forwards"}] [{"selector":"#anim-60f6a290-ed1d-4746-8aa9-8b53dd5f05ac","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-5f1d22c6-fcca-427c-98d0-d90024c2042d","keyframes":{"transform":["translate3d(121.01696%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b9231e50-8abc-46d6-b3f8-56dc882b8144","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-2dace8a4-99be-45db-930e-a76f449ac7a2","keyframes":{"transform":["translate3d(-119.59459%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Disclaimer *T&C Apply Open Account Now!